Symposium Overview

The Miami Cancer Institute Second Annual Women’s Cancer Symposium brings together a distinguished faculty from Harvard, Memorial Sloan Kettering and Miami Cancer Institute for a two-day symposium that will focus on the medical management of common and important challenges facing health-care professionals who care for women with cancer.  The multispecialty approach allows participants to explore new diagnoses and cutting-edge treatment options for various areas of breast and ovarian cancer patient care in a concise symposium format.

Symposium Directors
Gladys L. Giron, M.D., FACS
Starr K. Mautner, M.D., FACS
Nicholas C. Lambrou, M.D., FACOG
John P. Diaz, M.D., FACOG

 

mci logo

Topics this Year

Topics this Year

  • Management of High -risk Breast Cancer Patients
  • Serous Tubal Intraepithelial Carcinoma (STIC) Tumors
  • The Evolution of Treatment for HER2+ Breast Cancer
  • Updates in Breast Imaging
  • Ovarian Cancer: Recent Innovations and Standards of Care
  • Fertility Options for Cancer Survivors
  • Proton Therapy in Breast Cancer: Rationale, Applications and Challenges
  • The BRCA Patient and Gynecologic Options
  • Being a Voice for the Voiceless: How We Can Improve Breast Cancer Care for All
  • For a complete list of topics, please refer to agenda

Who should attend?

  • Breast Surgeons
  • Plastic Surgeons
  • Obstetricians and Gynecologists
  • Physiatrists
  • Geneticists
  • Pathologists
  • Radiation Oncologists
  • General Surgeons
  • General Practitioners
  • Oncologists
  • Medical Oncologists
  • Nurses
  • Psychiatrists
  • Radiologists
  • Other interested healthcare professionals

Sponsorship & Exhibit Information

On behalf of the symposium directors and the Baptist Health Continuing Medical Education Department we are pleased to invite you and your company to participate as a sponsor and exhibitor at our upcoming event.

Educational Objectives

Learn about the objectives that will be covered for this symposium.

 

International Attendees

Baptist Health South Florida is pleased to extend a discount to International Healthcare Professionals. Availability of this discount is limited.

 

Agenda*

*Schedule is subject change.

Details for the 2020 Agenda are pending. Please visit us at a later time.

Pending


Educational Objectives and Accreditation & Credits

Upon completion of this conference, participants should be better able to:

Educational Objectives

  • Recognize the changing landscape of genetic testing.
  • Review recent changes in National Comprehensive and Clinical Network (NCCN) guidelines.
  • Identify appropriate complexities related to genetic testing.
  • Develop an individualized treatment plan in coordination with a patients multi-disciplinary care team.
  • Determine when to collect fresh seroma fluid and representative portions of the capsule and send for pathology.
  • Describe risks associated with varying breast cancer risk factors.
  • Review options for screening among high risk cancer populations.
  • Summarize the major changes in ovarian cancer medical care.
  • Develop novel effective strategies for newly diagnosed patients.
  • Apply improved decision-making regarding treatment options for early stage disease.
  • Implement optimized treatment plans of patients with metastatic HER2+ disease.
  • Explore the advances and identify the benefits of tomosynthesis and tomosyntheis-guided biopsy.
  • Review recent studies and advances involving the utilization of breast MRI.
  • Explain the controversy surrounding breast density.
  • Compare ovarian and tubal cancer cases with and without STIC.
  • Identify gynecologic malignancies other than non-uterine serous pelvic carcinomas and benign gynecologic pathologies.
  • Identify young adults facing a diagnosis of cancer and implications of the disease and treatment on fertility potential.
  • List available options to preserve fertility potential and their advantages and limitations prior to cancer treatment.
  • Discuss the most prevalent cancer-related impairments among breast and gynecologic cancer survivors.
  • Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors.
  • Define integrative medicine.
  • Identify common integrative medicine therapies relevant to cancer care.
  • List a few common natural products containing a significant amount of phytoestrogens.
  • Create an understanding of the rationale for this new treatment modality.
  • List physical and dosimetric advantages.
  • Determine appropriate candidates for MRI-linac treatment.
  • Summarize advantages in implementing MRI-linac based treatments.
  • Describe gynecologic cancer-related impairments and their impact on the quality of life for the patient.
  • Explain the treatments of gynecologic cancer impairments.
  • Identify strategies to minimize barriers to early referral for cancer-related impairments.
  • Identify indications for autologous versus implant-based breast reconstruction.
  • Explain the risks and benefits of nipple-sparing mastectomy.
  • Explain strategies to minimize the risk of ALND among clinically node negative but pathologically node positive breast cancer patients.
  • Identify the differences in nodal pathologic complete response following neoadjuvant chemotherapy based on tumor receptor profile.
  • Implement a working roadmap for implementation of BRCA testing.
  • Identify a consortium to guide clinical BRCA issues in ovarian cancer.
  • Implement nerve sparing autologous breast reconstruction.
  • Assess the use of fat grafting.
  • Recognize the changing landscape of genetic testing.
  • Identify appropriate complexities related to genetic testing.
  • Describe breast cancer related impairments and their impact on the quality of life for the patient.
  • Identify strategies to minimize barriers to early referral for cancer related impairments.
  • Examine the physician’s role in accessing resources that allow healthcare providers to pursue the mission of curing and preventing breast cancer.

Accreditation and Credits

  • Baptist Health provides accredited continuing education (CME/CE) to doctors, nurses and allied health professionals.

  • Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

  • Baptist Health South Florida designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Automatically Reports
    To CE BROKER

  • This activity has been approved for 10.75 credit hours, CE Broker #20-698592, by the Florida Boards of Medicine, Osteopathic Medicine, Psychology (10.50 hours) and the Florida Council of Physician Assistants.

  • This activity has been approved for 10.50 contact hours each by Florida State Board of Nursing, Baptist Health South Florida. CE Broker Provider #50-182.

  • This activity has been approved for 10.75 contact hours by the Florida State Board of Occupational Therapy, Baptist Health South Florida. CE Broker Provider #50-182.

  • This activity has been approved for 10.75 contact hours for respiratory therapy personnel in the category of personal growth by the State of Florida, Baptist Health South Florida. CE Broker Provider #50-182.

  • The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Summit Registration

Registration Fees

Physicians (M.D., D.O., Psy.D., Ph.D.) $175**
Other Healthcare Professionals $95
Baptist Health Employees $60
($35 Fri. - $25 Sat.)
International Attendees ​ 

​Registration fee includes continental breakfast and lunch on Friday and continental breakfast ​and break on Saturday.

**Groups of 3 or more physicians who register together are eligible for a 20% discount.

*International physicians are eligible for a 20% discount.

Mail-In Registration

With check payment only to Baptist Health CME Department, 8900 North Kendall Drive, Miami, Florida 33176.

Online Registration

(Not Available at this Time)
  • Ms. Brinker has indicated that she has relevant financial relationships with commercial interest companies, she is a consultant for Hologic and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Dr. Cristian has indicated that he has relevant financial relationships with commercial interest companies, he receives book royalties from Demos Medical Publishers, Elsevier Medical Publishers and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    M. Beatriz Currier, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Gary Deng, M.D., Ph.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    John P. Diaz, M.D. indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Marcio Fagundes, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Allie Garcia-Serra, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Ginger J. Gardner, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Arelis E. Mártir-Negrón, M.D., FACMG, indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Deepa Masrani, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Miguel A. Medina III, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Niloofar Nasseri-Nik, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Steven J. Ory, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Melissa L. Pilewskie, MD., FACS, indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Ann E. Podrasky, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Harry M. Salinas, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Eric P. Winer, M.D., indicated that he has relevant financial relationships with commercial interest companies. He is a consultant with Genentech, LEAP, Lilly, Carrick Therapeutics and GSK. He is also a stock/shareholder with Verastem. He will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

    Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

  • All course activities (including educational sessions, meal functions, exhibit hall, etc.) are exclusively reserved for registered attendees. Non-registered guests (including children, family members, colleagues, etc.) are not allowed in the training areas. Badges provided at registration are required for entrance into all functions and will be strictly enforced.

  • In consideration of the Americans with Disabilities Act, please contact us to determine your special service requirements.

  • Changes may occur that are beyond our control. In the unforeseen event the symposium is canceled, Baptist Health will refund attendees the entire amount of their registration fees. If you are traveling from outside of the area, we strongly suggest purchasing travel insurance.

Faculty

  • Gladys L. Giron, M.D., FACS

    Gladys L. Giron, M.D., FACS

    Breast Surgical Oncology
    Cancer Liaison Physician
    Miami Cancer Institute

  • Starr K. Mautner, M.D., FACS

    Starr K. Mautner, M.D., FACS

    Breast Surgical Oncology
    Cancer Liaison Physician
    Miami Cancer Institute

  • Nicholas C. Lambrou, M.D., FACOG

    Nicholas C. Lambrou, M.D., FACOG

    Miami Orthopedics & Sports Medicine Institute

  • John P. Diaz, M.D., FACOG

    John P. Diaz, M.D., FACOG

    Director of Gynecologic Minimally Invasive Surgery
    Baptist Health South Florida
    Lead Physician Clinical Research
    Gynecologic Oncology Clinical Trials
    Miami Cancer Institute

Location and Accommodations

Location and Accommodations

Hilton Miami Dadeland
9100 North Kendall Drive Miami, Florida 33176
786-975-1920

Hurry and make your hotel reservation today! Mention code Wocasy to receive the special group rate of $189, plus applicable taxes.

NOTE: Partial credits are not available. Where credits are approved on a session-by-session basis, participants must attend each session in its entirety to receive complete credit for the session. (This does not apply to M.D.s and D.O.s.)

Photography

By attending our symposium, you consent to photography and videography of your image and likeness for use on Baptist Health websites, social media pages and press releases distributed for marketing purposes. Should you not agree to be photographed or recorded, you are responsible to notify us prior to this symposium.

Photography and recording of presenters and presentations are prohibited in the General Session, unless authorized by Baptist Health South Florida.

Disclaimer

Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.